Search Results - "Goth, M. I."

Efficacy of the New Long-Acting Formulation of Lanreotide (Lanreotide Autogel) in the Management of Acromegaly by Caron, Ph, Beckers, A., Cullen, D. R., Goth, M. I., Gutt, B., Laurberg, P., Pico, A. M., Valimaki, M., Zgliczynski, W.

“…Lanreotide Autogel is a new long-acting aqueous preparation of lanreotide for the treatment of acromegaly and is administered by deep sc injection from a small…”
Get full text

Pituitary adenylate cyclase activating polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors by Goth, M I, Lyons, C E, Canny, B J, Thorner, M O

“…GH secretion has been thought traditionally to be regulated by the two hypothalamic hormones, GH-releasing hormone (GHRH) and somatostatin (SRIF). Recent…”
Get more information

ESE audit on management of adult growth hormone deficiency in clinical practice by Martel-Duguech, Luciana, Jorgensen, Jens Otto L, Korbonits, Márta, Johannsson, Gudmundur, Webb, Susan M

“…Guidelines recommend adults with pituitary disease in whom GH therapy is contemplated, to be tested for GH deficiency (AGHD); however, clinical practice is not…”
Get full text

Activation of RAF/MEK/ERK and PI3K/AKT/mTOR pathways in pituitary adenomas and their effects on downstream effectors by Dworakowska, D, Wlodek, E, Leontiou, C A, Igreja, S, Cakir, M, Teng, M, Prodromou, N, Góth, M I, Grozinsky-Glasberg, S, Gueorguiev, M, Kola, B, Korbonits, M, Grossman, A B

“…Raf/MEK/ERK and phosphatidylinositol 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) cascades are key signalling pathways interacting with each other…”
Get full text

Effects of 24 months of growth hormone (GH) treatment on serum carboxylated and undercarboxylated osteocalcin levels in GH-deficient adults by Hubina, E, Lakatos, P, Kovács, L, Szabolcs, I, Rácz, K, Tóth, M, Szucs, N, Góth, M I

“…We studied the effect of growth hormone (GH) replacement on bone mineral density (BMD) and some parameters of bone metabolism, including undercarboxylated…”
Get full text

The effect of surgical treatment on secondary hyperaldosteronism and relative hyperinsulinemia in primary hyperparathyroidism by KOVACS, L, GOTH, M. I, SZABOLCS, I, DOHAN, O, FERENCZ, A, SZILAGYL, G

“…To evaluate the renin-aldosterone system and insulin secretion in hyperparathyroidism and their effects on blood pressure regulation. Studies were carried out…”
Get full text

The effect of gender and age on growth hormone replacement in growth hormone-deficient patients by Hubina, E, Kovács, L, Szabolcs, I, Szücs, N, Tóth, M, Rácz, K, Czirják, S, Görömbey, Z, Góth, M I

“…We analyzed the effect of growth hormone replacement therapy (36 months) analyzed at a dose adjusted to maintain serum insulin-like growth factor-I level…”
Get more information

Changes of serum calcium level following thyroid surgery--reasons and clinical implications by Kovács, L, Góth, M I, Vörös, A, Hubina, E, Szilágyi, G, Szabolcs, I

“…The reasons of transient hypocalcemia, frequently occurring after thyroid surgery, were investigated. Serum total calcium (seCa) and phosphorus (seP) levels…”
Get more information

Evaluation of the treatment of thyrotropin-secreting pituitary adenomas with a slow release formulation of the somatostatin analog lanreotide by KUHN, J. M, ARLOT, S, CATUS, F, ISPAS, S, BECK-PECCOZ, P, LEFEBVRE, H, CARON, P, CORTET-RUDELLI, C, ARCHAMBAUD, F, CHANSON, P, TABARIN, A, GOTH, M, BLUMBERG, J

“…Somatostatin analogs have been shown to be effective for the treatment of TSH-secreting pituitary adenomas. However, their use in this indication is limited by…”
Get full text

Dexamethasone and adrenocorticotropin suppress prolactin secretion in humans by Hubina, Erika, Nagy, György M, Tóth, Béla E, Iván, Gabriella, Görömbey, Zoltán, Szabolcs, István, Kovács, László, Góth, Miklós I

“…It has been demonstrated that the regulatory pathways mediating basal and/or stimulus-induced prolactin (PRL) release in mammals are highly sensitive to…”
Get full text

Determinants of cardiovascular risk in 2589 hypopituitary GH-deficient adults – a KIMS database analysis by Abs, Roger, Feldt-Rasmussen, Ulla, Mattsson, Anders F, Monson, John P, Bengtsson, Bengt-Åke, Góth, Miklós I, Wilton, Patrick, Koltowska-Häggström, Maria

“…Objective: The aim of the present study was to clarify the relationship between GH deficiency (GHD) and some cardiovascular risk factors and to analyse the…”
Get full text

Chronic estrogen treatment in male rats reveals mammosomatotropes and allows inhibition of prolactin secretion by somatostatin by Goth, M I, Lyons, C E, Ellwood, M R, Barrett, J R, Thorner, M O

“…Previous in vivo studies demonstrated that estrogen treatment of male rats allows somatostatin (SRIF) to inhibit PRL release. The objective of this study was…”
Get full text

Novel molecular aspects of pituitary adenomas by Hubina, E, Ruscica, M, Nanzer, A M, Czirják, S, Góth, M I, Grossman, A B, Korbonits, M

“…Ghrelin stimulates while somatostatin inhibits GH release and they thus serve as functional antagonists. We have compared their effects on cell proliferation…”
Get full text

Protein western array analysis in human pituitary tumours: insights and limitations by Ribeiro-Oliveira, Antônio, Franchi, Giulia, Kola, Blerina, Dalino, Paolo, Pinheiro, Sérgio Veloso Brant, Salahuddin, Nabila, Musat, Madalina, Góth, Miklós I, Czirják, Sándor, Hanzély, Zoltán, da Silva, Deivid Augusto, Paulino, Eduardo, Grossman, Ashley B, Korbonits, Márta

“…The molecular analysis of pituitary tumours has received a great deal of attention, although the majority of studies have concentrated on the genome and the…”
Get full text

Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake by Kovács, Gábor L, Gonda, Gábor, Vadász, Gizella, Ludmány, Eva, Uhrin, Katalin, Görömbey, Zoltán, Kovács, László, Hubina, Erika, Bodó, Miklós, Góth, Miklós I, Szabolcs, István

“…The prevalence of thyroid microcarcinomas found at autopsies is 100-1000 times higher than in clinical cancer. The epidemiological and histological…”
Get more information

Sheehan’s syndrome: baseline characteristics and effect of 2 years of growth hormone replacement therapy in 91 patients in KIMS – Pfizer International Metabolic Database by Keleştimur, Fahrettin, Jonsson, Peter, Molvalilar, Senay, Gomez, Jose Manuel, Auernhammer, Christoph J, Colak, Ramiz, Koltowska-Häggström, Maria, Goth, Miklos I

“…Objective: Sheehan’s syndrome occurs as a result of ischaemic pituitary necrosis due to severe postpartum haemorrhage. It is one of the most important causes…”
Get full text

Isolated growth hormone (GH) deficiency in adult patients: Baseline clinical characteristics and responses to GH replacement in comparison with hypopituitary patients. A sub-analysis of the KIMS database by Abs, Roger, Mattsson, Anders F., Bengtsson, Bengt-Åke, Feldt-Rasmussen, Ulla, Góth, Miklós I., Koltowska-Häggström, Maria, Monson, John P., Verhelst, Johan, Wilton, Patrick

“…Isolated growth hormone deficiency (IGHD) provides the ideal model to characterize GHD without interference from other pituitary deficiencies or their…”
Get full text

Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: A KIMS-based study by Casanueva, Felipe F., Leal, Alfonso, Koltowska-Häggström, Maria, Jonsson, Peter, Góth, Miklós I.

“…Casanueva FF, Leal A, Koltowska-Häggström M, Jonsson P, Góth MI. Traumatic brain injury as a relevant cause of growth hormone deficiency in adults: a…”
Get full text

Treatment of pituitary tumors: dopamine agonists by Iván, Gabriella, Szigeti-Csúcs, Nikoletta, Oláh, Márk, Nagy, György M, Góth, Miklós I

“…The neurotransmitter/neuromodulator dopamine plays an important role in both the central nervous system and the periphery. In the hypothalamopituitary system…”
Get full text

Chronic estrogen treatment in male rats reveals mammosomatotropes and allows inhibition of prolactin secretion by somatostatin by Goth, M I, Lyons, C E, Ellwood, M R, Barrett, J R, Thorner, M O

“…Previous in vivo studies demonstrated that estrogen treatment of male rats allows somatostatin (SRIF) to inhibit PRL release. The objective of this study was…”
Get full text